相关实验视频
Updated: May 3, 2026

11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
15.9K
上皮层癌与非岛状细胞瘤低血糖症:一个病例报告
Yunpeng Li1, Rui Yang2, Liang Zhang3
1Department of Urology, Hexi University Affiliated Zhangye People's Hospital, Zhangye, Gansu 734000, P.R. China.
Oncology letters
|March 20, 2025
概括
上皮层癌 (ACC) 可能导致严重的低血糖症,这是一个罕见但危险的并发症. 及时诊断和手术治疗ACC对于管理这种具有挑战性的疾病至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 上皮层癌 (ACC) 是一种罕见的内分泌恶性瘤,预后不佳.
- 通常情况下,ACC会出现高血糖和库希综合征.
- 低血糖是ACC的一种罕见但至关重要的表现.
研究的目的:
- 报告一种罕见的副腎皮質癌症病例,呈現嚴重低血糖症.
- 突出诊断挑战和ACC相关低血糖的管理.
- 为了提高人们对这种不寻常的副瘤综合征的认识.
主要方法:
- 一个53岁妇女的病例报告,患有反复出现的低血糖昏迷.
- 对右侧上腺皮质癌的诊断.
- 成功的手术治疗瘤.
主要成果:
- 患者经历了反复的,不受控制的低血糖和低血糖昏迷.
- 上腺皮质癌被诊断为非岛屿细胞瘤低血糖症的原因.
- 对ACC的手术切除导致低血糖症的成功解决.
结论:
- 上腺皮质癌可以表现为严重的低血糖症,这给诊断和治疗带来了挑战.
- 早期识别和迅速的手术干预对于管理与ACC相关的低血糖至关重要.
- 对于治疗内分泌疾病的临床医生来说,意识到这种罕见的呈现是必不可少的.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Hypoglycemia
30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Diabetic Ketoacidosis l: Introduction
30
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
30

